Skip to content
clinical trials latin america
  • Sites and Network
Menu
  • Sites and Network
  • Español
Linkedin Twitter Facebook-f Youtube
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Our Science
    • News
  • Contact
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Insights
    • Our Science
    • News
  • Contact
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español
Menu
  • Home
  • Services
    • Early Phase Trials
    • Phase II & III Trials
    • Medical Devices
    • Rescue Studies
  • About Cohortias
    • Commitment
    • Team
    • Why Latin America
    • Our Story
  • Insights
    • News
    • Our Science
  • Trials
    • Argentina
    • Brazil
    • Colombia
    • Mexico
  • Contact
  • Ir a sitio en español

Author: quickappsmkt

This author has written 337 articles
  1. Home>
  2. quickappsmkt
Read more about the article Clinical Trial – Phase 2 new covid-19 booster trial.
booster

Clinical Trial – Phase 2 new covid-19 booster trial.

  • Post author:quickappsmkt
  • Post published:May 9, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

In the trial, vaccination with ABNCoV2 led to a substantial improvement in neutralizing antibodies against the Omicron variant.

Continue ReadingClinical Trial – Phase 2 new covid-19 booster trial.
Read more about the article First-in-Human – Phase 3 knee osteoarthritis trial.
osteoarthritis

First-in-Human – Phase 3 knee osteoarthritis trial.

  • Post author:quickappsmkt
  • Post published:May 6, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will evaluate the change in pain and function following subcutaneous injections of PPS versus placebo.

Continue ReadingFirst-in-Human – Phase 3 knee osteoarthritis trial.
Read more about the article Clinical Trial – Phase 2 hepatocellular carcinoma therapy.
hepatocellular

Clinical Trial – Phase 2 hepatocellular carcinoma therapy.

  • Post author:quickappsmkt
  • Post published:May 5, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The open-label trial will assess the safety and efficacy of GT90001 plus Nivolumab in patients with advanced HCC.

Continue ReadingClinical Trial – Phase 2 hepatocellular carcinoma therapy.
Read more about the article Clinical Trial – Treatment for glioblastoma multiforme.
glioblastoma multiforme

Clinical Trial – Treatment for glioblastoma multiforme.

  • Post author:quickappsmkt
  • Post published:May 3, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Assessing the overall survival is the primary endpoint of the global trial.

Continue ReadingClinical Trial – Treatment for glioblastoma multiforme.
Read more about the article First-in-Human – Phase 1 osteoporosis drug trial.
osteoporosis

First-in-Human – Phase 1 osteoporosis drug trial.

  • Post author:quickappsmkt
  • Post published:April 29, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will assess the safety, tolerability, and pharmacokinetics of TST002 to treat individuals with osteoporosis.

Continue ReadingFirst-in-Human – Phase 1 osteoporosis drug trial.
Read more about the article Clinical Trial – Phase 3 idiopathic hypersomnia treatment.
hypersomnia

Clinical Trial – Phase 3 idiopathic hypersomnia treatment.

  • Post author:quickappsmkt
  • Post published:April 28, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The randomized, double-blind trial of Wakix will enroll nearly 200 IH patients in 60 to 80 trial sites in the US.

Continue ReadingClinical Trial – Phase 3 idiopathic hypersomnia treatment.
Read more about the article Clinical Trial – Acute myeloid leukemia therapy.
acute myeloid leukaemia

Clinical Trial – Acute myeloid leukemia therapy.

  • Post author:quickappsmkt
  • Post published:April 26, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The company intends to commence the trial in the second half of this year.

Continue ReadingClinical Trial – Acute myeloid leukemia therapy.
Read more about the article Clinical Trial – Phase I trial for E. Coli treatment.
e. coli

Clinical Trial – Phase I trial for E. Coli treatment.

  • Post author:quickappsmkt
  • Post published:April 25, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

The trial will analyze SNIPR001’s safety and tolerability and its effect on decreasing the colonization of E. Coli in the gut.

Continue ReadingClinical Trial – Phase I trial for E. Coli treatment.
Read more about the article Clinical Trials – New diabetic foot ulcer treatment.
treatment

Clinical Trials – New diabetic foot ulcer treatment.

  • Post author:quickappsmkt
  • Post published:April 21, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Cynata Therapeutics has started clinical trials with an initial cohort of patients in Adelaide of its patented product, aimed at treating diabetic foot ulcers.

Continue ReadingClinical Trials – New diabetic foot ulcer treatment.
Read more about the article Cohortias – Contract Research Organization of Latin America.
latin america

Cohortias – Contract Research Organization of Latin America.

  • Post author:quickappsmkt
  • Post published:April 19, 2022
  • Post category:Cohortias Blog
  • Post comments:0 Comments

Global pharmaceutical companies have been running clinical trials in Latin America for over 20 years.

Continue ReadingCohortias – Contract Research Organization of Latin America.
  • 1
  • 2
  • 3
  • 4
  • …
  • 34
  • Go to the next page

Direct Contact

[email protected]
covid clinical trials
  • [email protected]
  • +52 81 2719 3064
  • C. Del Comercio 565, SPGG, N.L. México.
  • Privacy Policy

Solutions

  • Full Service CRO
  • Research & Development
  • Study Design
  • Sites Activation
  • Protocol Writing

Company

  • Cohortias Core
  • Background
  • Locations
  • Team Members
  • Opportunities

get started

  • Know Latin America
  • Standard-of-care
  • Regulatory Infrastructure
  • Cases & Evidence
  • Resources

Quarterly Newsletter

Cohortias International © All rights reserved

Linkedin Twitter Facebook-f Youtube